Merit Financial Group, LLC Amgen Inc Transaction History

Merit Financial Group, LLC

$6.49 Billion
Q1 2025

A detailed history of Merit Financial Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Merit Financial Group, LLC holds 20,252 shares of AMGN stock, worth $5.66 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

20,252

Previous 18,643 8.63%

Holding current value

$5.66 Million

Previous $4.86 Million 29.84%

% of portfolio

0.1%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 09, 2025	BUY	$258.59 - $327.36 $416,071 - $526,722	1,609 Added 8.63%	20,252 $6.31 Million
Q4 2024 Jan 15, 2025	BUY	$258.78 - $328.31 $1.15 Million - $1.46 Million	4,447 Added 31.33%	18,643 $4.86 Million
Q3 2024 Oct 17, 2024	SELL	$309.38 - $337.38 $1.35 Million - $1.47 Million	-4,364 Reduced 23.51%	14,196 $4.57 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $106,939 - $129,959	407 Added 2.24%	18,560 $5.8 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $2.41 Million - $2.91 Million	8,952 Added 97.29%	18,153 $5.16 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $309,652 - $349,325	-1,211 Reduced 11.63%	9,201 $2.65 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $614,187 - $762,531	2,809 Added 36.95%	10,412 $2.8 Million
Q2 2023 Aug 01, 2023	BUY	$214.27 - $253.37 $350,331 - $414,259	1,635 Added 27.4%	7,603 $1.69 Million
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $279,302 - $340,422	1,237 Added 26.15%	5,968 $1.44 Million
Q4 2022 Jan 13, 2023	BUY	$229.03 - $291.01 $94,589 - $120,187	413 Added 9.56%	4,731 $0
Q3 2022 Oct 31, 2022	SELL	$224.46 - $253.15 $337,138 - $380,231	-1,502 Reduced 25.81%	4,318 $973,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $812,791 - $904,495	3,523 Added 153.37%	5,820 $1.42 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $141,867 - $156,942	647 Added 39.21%	2,297 $555,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $27,843 - $31,864	-140 Reduced 7.82%	1,650 $371,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $15,707 - $18,403	-74 Reduced 3.97%	1,790 $381,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $61,197 - $67,894	-262 Reduced 12.32%	1,864 $454,000
Q1 2021 May 18, 2021	BUY	$221.91 - $258.6 $47,932 - $55,857	216 Added 11.31%	2,126 $529,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $15,795 - $18,809	-73 Reduced 3.68%	1,910 $439,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $38,951 - $43,317	166 Added 9.14%	1,983 $504,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $7,714 - $9,466	-39 Reduced 2.1%	1,817 $428,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $10,752 - $14,260	59 Added 3.28%	1,856 $376,000
Q4 2019 Jan 16, 2020	BUY	$189.21 - $243.2 $340,010 - $437,030	1,797 New	1,797 $433,000

Others Institutions Holding AMGN

# of Institutions

3,306

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.

Account

Merit Financial Group, LLC Amgen Inc Transaction History